Strategies to optimize lung cancer outcomes

Sponsored Content by AstraZenecaMay 31 2024Reviewed by Emily Magee Since the 1950s, lung cancer has been the leading cause of cancer deaths among men in the United States. In the 1980s, this expanded to women, including a growing incidence in those who had never smoked.1

In addition to late diagnosis, there are also variations in the time between diagnosis and treatment, which adversely affects survival outcomes. Clear disparities exist around the world when it comes to patient pathways. For example: Early lung cancer does not always present with signs or symptoms, which adds to delays in diagnosis.10 Furthermore, early symptoms such as a persistent cough11 could be mistaken for other conditions by both patients and HCPs, particularly in those who have never smoked, causing further delays in opportunities to test and diagnose. Primary care HCPs may benefit from heightened awareness and understanding of this deadly condition.

The LAA Ambition, Improvement, Measurement reports published in 2022 and 2023 were developed to provide details of the barriers currently preventing screening, diagnosis, and treatment for lung cancer and strategies for tackling these barriers. The LAA’s two additional AIM reports, Establishing a Pathway to Biomarker Testing and Optimising Multi-Disciplinary / Tumour Board Care, go deeper into which areas need to be addressed to ensure a successful level of care, including the accessibility of effective, innovative treatments.

Whilst the main responsibility for the improvements listed above falls to leading professional societies who should develop recommended global guidelines for biomarker testing infrastructure and national implementation of MDTs, these practices can be integrated within today’s lung cancer clinics . Clear benchmarks and KPIs would allow teams to measure the effectiveness of their MDTs, e.g., assessing the time taken from diagnosis to treatment and access to biomarker testing.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

inflammatory protein research offers treatment strategies for a rare, potentially fatal lung diseaseMost of the time, our immune systems do a great job defending against infection and keeping our bodies running smoothly. Sometimes, though, our immune system actually makes things worse.
Source: medical_xpress - 🏆 101. / 51 Read more »

Longer use of breathing device supports lung growth in preterm infants, research findsExtending the use of a continuous positive airway pressure (CPAP) treatment in premature infants by two weeks significantly increases lung volume and lung diffusion capacity, according to a new study. The research will be presented at the Pediatric Academic Societies (PAS) 2024 Meeting, held May 2–6 in Toronto.
Source: medical_xpress - 🏆 101. / 51 Read more »